Literature DB >> 22451956

Type A behavior and central serous chorioretinopathy.

Lawrence A Yannuzzi.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22451956     DOI： 10.1097/iae.0b013e31823ff9a6

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  14 in total

1.  Obstructive sleep apnea and central serous chorioretinopathy.

Authors:  Frank L Brodie; Emily S Charlson; Tomas S Aleman; Rebecca T Salvo; Dina Y Gewaily; Marisa K Lau; Neil D Farren; Stephanie B Engelhard; Maxwell Pistilli; Alexander J Brucker
Journal:  Retina       Date:  2015-02       Impact factor: 4.256

2.  The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.

Authors:  Emine Çiloğlu; Fikret Unal; Nese Cetin Dogan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-18       Impact factor: 3.117

3.  QT interval dispersion in the patients with central serous chorioretinopathy.

Authors:  Necati Dagli; Burak Turgut; Rumeysa Tanyildizi; Sabiha Kobat; Mehmet Ali Kobat; Orhan Dogdu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

Review 4.  Photodynamic therapy for central serous chorioretinopathy.

Authors:  O C Erikitola; R Crosby-Nwaobi; A J Lotery; S Sivaprasad
Journal:  Eye (Lond)       Date:  2014-06-20       Impact factor: 3.775

Review 5.  Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.

Authors:  Francesco Sartini; Michele Figus; Marco Nardi; Giamberto Casini; Chiara Posarelli
Journal:  Eye (Lond)       Date:  2019-03-01       Impact factor: 3.775

6.  Flat choroidal melanoma masquerading as central serous chorioretinopathy.

Authors:  Timothy Patrick Higgins; Chloe T L Khoo; George Magrath; Carol L Shields
Journal:  Oman J Ophthalmol       Date:  2016 Sep-Dec

7.  Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy.

Authors:  Muhammet Kazim Erol; Ayse Balkarli; Ozgur Yucel; Yusuf Akar; Berna Dogan; Elcin Suren
Journal:  Ther Clin Risk Manag       Date:  2017-07-28       Impact factor: 2.423

8.  Temperament and character personality profile and illness-related stress in central serous chorioretinopathy.

Authors:  Rupert Conrad; Franziska Geiser; Alexandra Kleiman; Berndt Zur; Andrea Karpawitz-Godt
Journal:  ScientificWorldJournal       Date:  2014-02-16

9.  Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment.

Authors:  Jin Young Kim; Ju Byung Chae; Jisoo Kim; Dong Yoon Kim
Journal:  J Ophthalmol       Date:  2018-07-22       Impact factor: 1.909

Review 10.  Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature.

Authors:  Irini Chatziralli; Aikaterini Vlachodimitropoulou; Chrysoula Daoula; Christina Vrettou; Eleni Galani; George Theodossiadis; Panagiotis Theodossiadis
Journal:  Int J Retina Vitreous       Date:  2018-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.